Mr. Angevine, you talked earlier about some of the specific regulatory hurdles that you identified that stand in the way, and you mentioned the NEB and some of the things around them. I'm just wondering if you have some other things that you could identify that would be regulatory hurdles that this committee could address in our report later.
On February 1st, 2011. See this statement in context.